Summary:
Click image to enlargeA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide, an FDA approved drug, on the Reduction of Morbidity and Mortality in Adults with Obesity
Criteria:Must be 40 years of age or older
Must have a history of heart disease, heart attack, or stroke
Qualified Participants May Receive:
Compensation if qualified
Opprtunity to receive approved weight loss medication